SYROS PHARMACEUTICALS, INC. Operating Lease, Expense
SYROS PHARMACEUTICALS, INC. reported Operating Lease, Expense of $76.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2023-12-31 was $3.00K, a 95.38% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2023-09-30 was $4.00K, a 93.85% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2023-06-30 was $3.00K, a 95.38% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, expense for the quarter ending 2023-03-31 was $66.00K, a 0.00% change year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, expense for fiscal 2023 was $76.00K, a 70.88% decline from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. operating lease, expense for fiscal 2022 was $261.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $7.00K derived: sum of 2 quarters · filed 2024-10-31 | $10.00K derived: sum of 3 quarters · filed 2024-10-31 | $76.00K 10-K · filed 2024-03-27 |
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $7.00K derived: sum of 2 quarters · filed 2024-10-31 | $73.00K 10-Q · filed 2024-10-31 | $138.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $69.00K 10-Q · filed 2024-07-31 | $134.00K derived: sum of 3 quarters · filed 2024-07-31 | $199.00K derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $66.00K 10-Q · filed 2024-05-14 | $131.00K derived: sum of 2 quarters · filed 2024-05-14 | $196.00K derived: sum of 3 quarters · filed 2024-05-14 | $261.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $130.00K derived: sum of 2 quarters · filed 2024-03-27 | $195.00K derived: sum of 3 quarters · filed 2024-03-27 | $261.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $130.00K derived: sum of 2 quarters · filed 2023-11-14 | $196.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $131.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $66.00K 10-Q · filed 2023-05-10 |